Skip to main content
B

BIO-GENE TECHNOLOGY LTD — Investor Relations & Filings

Ticker · BGT ISIN · AU000000BGT8 ASX Professional, scientific and technical activities
Filings indexed 449 across all filing types
Latest filing 2025-02-26 Regulatory Filings
Country AU Australia
Listing ASX BGT

About BIO-GENE TECHNOLOGY LTD

https://bio-gene.com.au/

Bio-Gene Technology Ltd is a technology company focused on the development and commercialization of novel insecticides derived from naturally occurring chemistry. The company addresses the global challenge of insecticide resistance through its proprietary platform based on beta-triketone chemistry. Its primary product candidates include Flavocide, a nature-identical version of a compound found in specific eucalyptus species, and Qcide, a natural oil extract. These solutions are designed for diverse applications, including crop protection, grain storage, public health, and animal health. By utilizing a unique mode of action, the company provides alternatives to traditional chemical pesticides, aiming to deliver effective pest management with a favorable safety profile for non-target organisms and the environment.

Recent filings

Filing Released Lang Actions
Appendix 4D and Half-Year Accounts 31 December 2024 20 pages 1.1MB
Regulatory Filings
2025-02-26 English
BGT Investor Webinar 4-Feb-25 Slides 7 pages 620.7KB
Regulatory Filings
2025-02-03 English
Investor Webinar Tue 4 Feb 2025 1 page 152.1KB
Regulatory Filings
2025-01-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 517.0KB
Regulatory Filings
2025-01-29 English
BGT Awarded U.S. Department of Defense Grants 4 pages 266.7KB
Regulatory Filings
2025-01-28 English
Notification of cessation of securities - BGT 4 pages 14.6KB
Regulatory Filings
2024-12-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.